T50.912 Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm

Name of the Condition

• Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm (ICD-10 Code: T50.912)

Summary

This condition involves intentional self-harm resulting from exposure to multiple unspecified drugs, medicaments, or biological substances. The term "multiple" indicates more than one substance is involved, while "unspecified" means the exact agents are not identified or documented. "Intentional self-harm" specifies the event was deliberate, influencing clinical assessment, management, and documentation requirements.

Causes

Intentional self-harm by multiple unspecified substances typically occurs due to deliberate ingestion, inhalation, or contact with medications or biological agents. The exact cause may be unknown or unspecified when the substances are not identified, but the intent is confirmed through clinical evaluation or patient history.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety)
• Prior self-harm or suicide attempts
• Access to multiple medications (e.g., prescription or over-the-counter)
• Substance misuse or dependence
• Social or environmental stressors

Symptoms

Symptoms can vary widely depending on the substances involved and may include nausea, vomiting, dizziness, altered mental status, respiratory distress, or cardiovascular instability. The presentation may be nonspecific when the exact agents are unknown.

Diagnosis

Diagnosis is based on clinical evaluation, including patient history (when available), physical examination, and laboratory testing. Toxicology screening may be performed, but the term "unspecified" applies when specific substances are not identified. Documentation of intent (intentional self-harm) is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the underlying intent. This may include decontamination, supportive care, antidotes (if applicable), and psychiatric evaluation. The specific approach depends on the clinical presentation and identified substances.

Prognosis and Follow-Up

Prognosis varies based on the substances involved, severity of exposure, and timely intervention. Follow-up care often includes psychiatric support, medication management, and safety planning to reduce future risk. Long-term outcomes depend on the resolution of acute effects and ongoing mental health care.

Complications

Potential complications include organ damage (e.g., liver, kidney), respiratory failure, seizures, or cardiovascular instability. Delayed recognition or treatment may increase the risk of severe outcomes.

Lifestyle & Prevention

Prevention strategies include secure storage of medications, limiting access to harmful substances, and addressing underlying mental health concerns. Education on safe medication use and recognizing signs of self-harm is also important.

When to Seek Professional Help

Seek immediate medical attention if self-harm is suspected or if symptoms of poisoning (e.g., confusion, difficulty breathing, severe nausea) occur. Prompt evaluation is critical for managing acute effects and preventing complications.

Tips for Medical Coders

Document the intent (intentional self-harm) clearly in the medical record, as this is required for accurate coding of T50.912. If the substances are identified, use more specific codes. Ensure the encounter type (e.g., initial, subsequent) is documented to support appropriate code assignment.